Toshihiko Agatsuma Selected Research

Toshihiko Agatsuma Research Topics

Disease

7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2011
5	Lung Neoplasms (Lung Cancer) 01/2019 - 07/2009
4	Neoplasms (Cancer) 01/2011 - 03/2010
3	Thymoma (Thymic Carcinoma) 12/2011 - 06/2010
2	Pneumonia (Pneumonitis) 01/2022 - 10/2009
2	Fever (Fevers) 01/2015 - 03/2010
2	Exanthema (Rash) 03/2013 - 10/2005
2	Hypoxia (Hypoxemia) 01/2010 - 10/2009
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2010 - 10/2009
1	Inflammation (Inflammations) 01/2022
1	Empyema 04/2018
1	Tuberculous Empyema 04/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Asthma (Bronchial Asthma) 01/2017
1	Diarrhea 11/2016
1	Chest Pain (Chest Pains) 01/2015
1	Emphysema 05/2011
1	Autoimmune Pancreatitis 01/2011
1	Teratoma (Teratoid Tumor) 01/2011
1	Nonseminomatous germ cell tumor 01/2011
1	Pathologic Constriction (Stenosis) 01/2011
1	Disease Progression 01/2011
1	Lymphadenopathy 01/2011
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2011
1	Malignant Mesothelioma 12/2010
1	Carcinoma (Carcinomatosis) 03/2010
1	Human Influenza (Influenza) 01/2010
1	Respiratory Insufficiency (Respiratory Failure) 01/2010
1	Hypotension (Low Blood Pressure) 01/2010
1	Rheumatoid Arthritis 10/2009
1	Dizziness (Lightheadedness) 07/2009
1	Fatigue 07/2009
1	Hemolytic Anemia 07/2009
1	Anemia 07/2009
1	Hypersensitivity (Allergy) 10/2005
1	Myocardial Infarction 09/2005
1	Atrial Heart Septal Defects (Atrial Septal Defect) 03/2005
1	Ebstein Anomaly (Ebsteins Anomaly) 03/2005
1	Supraventricular Tachycardia 03/2005

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2010 - 10/2005
3	ErbB Receptors (EGF Receptor)IBA 11/2016 - 11/2012
3	Gemcitabine FDA Link 12/2010 - 07/2009
2	AfatinibIBA 01/2019 - 11/2016
2	Gefitinib (Iressa)FDA Link 03/2013 - 11/2012
2	Platinum Compounds (Compounds, Platinum)IBA 12/2011 - 06/2010
2	EnzymesIBA 05/2011 - 09/2005
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2011 - 10/2009
2	Docetaxel (Taxotere)FDA Link 03/2010 - 07/2009
2	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2010 - 01/2010
1	AlbuminsIBA 01/2022
1	durvalumabIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2018
1	IronIBA 01/2018
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2017
1	Alanine Transaminase (SGPT)IBA 03/2013
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2013
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2012
1	Tyrosine Kinase InhibitorsIBA 11/2012
1	Vincristine (Oncovin)FDA LinkGeneric 12/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2011
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2011
1	Biological ProductsIBA 05/2011
1	AntioxidantsIBA 05/2011
1	SmokeIBA 05/2011
1	Cyclin D1IBA 01/2011
1	Fluorouracil (Carac)FDA LinkGeneric 01/2011
1	Antineoplastic Agents (Antineoplastics)IBA 01/2011
1	Prednisolone (Predate)FDA LinkGeneric 01/2011
1	Immunoglobulins (Immunoglobulin)IBA 01/2011
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2011
1	Vinorelbine (Navelbine)FDA LinkGeneric 12/2010
1	Pemetrexed (MTA)FDA Link 12/2010
1	amrubicinIBA 06/2010
1	Cisplatin (Platino)FDA LinkGeneric 06/2010
1	PlatinumIBA 06/2010
1	AnthracyclinesIBA 06/2010
1	nedaplatinIBA 06/2010
1	Etanercept (Enbrel)FDA Link 10/2009
1	Hemoglobins (Hemoglobin)IBA 07/2009
1	Dapsone FDA Link 10/2005

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2019 - 03/2010
6	Therapeutics 01/2022 - 10/2009
2	Combination Drug Therapy (Combination Chemotherapy) 12/2011 - 03/2010
2	Artificial Respiration (Mechanical Ventilation) 01/2010 - 10/2009
2	Hemoperfusion 01/2010 - 01/2010
1	Chemoradiotherapy 01/2022
1	Conservative Treatment 01/2015
1	Radiofrequency Ablation 01/2015
1	Salvage Therapy 11/2012
1	Critical Care (Surgical Intensive Care) 01/2010
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 10/2009
1	Plasma Exchange 10/2005
1	Catheter Ablation 03/2005